APA (7th ed.) Citation

Berger, P. B., & Hacke, W. (2010). Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Circulation, 121(23), .

Chicago Style (17th ed.) Citation

Berger, Peter B., and Werner Hacke. "Bleeding Complications with Dual Antiplatelet Therapy Among Patients with Stable Vascular Disease or Risk Factors for Vascular Disease: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) Trial." Circulation 121, no. 23 (2010).

MLA (9th ed.) Citation

Berger, Peter B., and Werner Hacke. "Bleeding Complications with Dual Antiplatelet Therapy Among Patients with Stable Vascular Disease or Risk Factors for Vascular Disease: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) Trial." Circulation, vol. 121, no. 23, 2010.